3 Ways to Put Medicine in Reach in 2017

Dec 28, 2016
As conversations on drug prices reaches a fever-pitch, 3 reasons for optimism emerge as we enter 2017.

Year in Review

1. For Diabetics, Insulin price gets in line

Diabetes

For the past five years, diabetes drugs have been the leading driver of traditional drug spend. Recently, Express Scripts partnered with Eli Lilly and Blink Health to provide a 40% discount on insulin products for patients with diabetes who are uninsured or underinsured. Our Diabetes Care Value program is the industry’s most comprehensive approach to help our clients control costs for people with diabetes.

2. There’s new hope in biologics for 10M patients

Watch

Approximately 10 million Americans live with an inflammatory condition. The biologic medications used to treat these conditions became the country’s costliest therapy class in 2015, representing 9.8% of all U.S. pharmacy spending. Specialized care from the Rheumatoid Arthritis and Inflammatory Disease Therapeutic Resource Center®, provides a unique savings guarantee to participating plan sponsors if a patient discontinues any preferred anti-inflammatory medication within the first 90 days. This helps patients with Rheumatoid Arthritis get access to the specialized care they need and a proven therapy that works for them while controlling costs for plan sponsors.

3. We’re getting scrappy when it comes to “affordable care”

Year in review

Health insurance deductibles, premiums and pharmacy benefits are decisions many U.S. companies make each year. The majority of nonelderly people get their health coverage through an employer-based plan. Controlling plan sponsor spending in spite of the rising pharmacy cost is critical to making healthcare more affordable and accessible to more Americans. Pharmacy benefit cost-saving solutions, including smart formulary management, allowed Express Scripts clients to hold their 2015 increase in drug spend to 3.3% - nearly two percentage points lower than the national average. If all U.S. plans adopted similar strategies, national drug spend would have been reduced by $6 billion. By leveraging size and scale, Express Scripts negotiates with manufacturers to achieve lower prices for patients and plan sponsors. And for those eligible for Medicare, Express Scripts offers Part D prescription drug coverage direct to consumers to close the donut hole.

At Express Scripts, we believe 2017 will be the year of a more informed and involved healthcare consumer. We look forward to working together with patients, our clients, manufactures, suppliers, and policymakers to put medicine within reach for 85 million Americans.

Author Bio

Lab Staff
comments powered by Disqus